Discovering biomarkers associated and predicting cardiovascular disease with high accuracy using a novel nexus of machine learning techniques for precision medicine

Personalized interventions are deemed vital given the intricate characteristics, advancement, inherent genetic composition, and diversity of cardiovascular diseases (CVDs). The identified biomarkers served as potential indicators for early detection of CVDs.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 The appropriate utilization of artificial intelligence (AI) and machine learning (ML) methodologies can yield novel understandings of CVDs, enabling improved personalized treatments through predictive analysis and deep phenotyping.
• 2 In this study, we proposed and employed a new approach combining traditional statistics and a nexus of cutting-edge AI/ML techniques to identify significant biomarkers for our predictive engine by analyzing the complete transcriptome of CVD patients.
• 3 After robust gene expression data pre-processing, we utilized three statistical tests (Pearson correlation, Chi-square test, and ANOVA) to assess the differences in transcriptomic expression and clinical characteristics between healthy individuals and CVD patients.

This research advances how AI systems learn, reason, and solve problems — with direct implications for automation and scientific discovery.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: